Does a peptide certificate of analysis prove a vial is safe?

What does a certificate actually describe?

A useful report identifies the sample, batch or lot, testing laboratory, test dates, methods, results and limits. Check whether it refers to the substance before manufacturing or the finished vial, and whether the batch identifier and product match. A seller-provided file may not establish how the sample was selected, whether it represents the vial in hand, or whether the laboratory issued it. Matching numbers or a logo alone cannot verify authenticity or quality. For a prescribed medicine, the dispensing pharmacy can answer product-specific questions.1

Is 99% purity the same as the right dose?

No. Identity asks what a substance is; strength or content asks how much is present; purity and impurities address other components detected by a particular method. A result described as “99% pure” needs its method, calculation and scope: it is not automatically proof that the labelled amount is present or that every possible impurity was measured. FDA describes different analytical methods and specifications for identity, strength, quality and purity in investigational drug documentation. A single result cannot establish clinical benefit.

For example, a report may calculate a percentage from the area of a main peak compared with the total area of peaks included in a chromatography test. Those peaks are detector signals, not a direct weighing of everything in the vial. A 99% peak-area result therefore cannot by itself establish that 99% of the vial’s contents by weight is the stated peptide, or that the main peak has the claimed identity. Different components can produce different detector responses, and a method may not measure water, salts or other substances. The EMA’s synthetic-peptide guideline treats identity, purity, content, water and other relevant impurities as separate quality questions. It is guidance for medicine development, not certification of an online product.145

Does a purity test prove sterility or low endotoxin?

No. Sterility testing looks for viable microorganisms under specified conditions. Bacterial endotoxins are components of certain bacteria that may remain even when viable organisms are not detected; they are a separate testing question. FDA notes both the limitations of sterility tests and the need for a broader manufacturing control strategy. An absence of detected growth in a sample is not proof that every vial is sterile. A purity chromatogram or a clear-looking solution does not answer either question.2

What happened when researchers tested online vials?

In a 2024 investigation, researchers attempted purchases from six selected online sellers offering semaglutide without a prescription. Three injection vials arrived. Their measured semaglutide content exceeded their labels; no viable microorganisms were detected under the tests, but endotoxin was detected in all three. The researchers also reported low measured purity by their method. These were a tiny, deliberately selected set of semaglutide products, not GLOW or KLOW, and cannot establish how common any problem is or the quality of another product. The findings illustrate why different tests are not interchangeable.3

What about combinations and storage?

A report on an individual ingredient does not establish the identity, stability or safety of a finished mixture. Seller-defined combinations such as GLOW and KLOW may vary in composition, and evidence for an ingredient is not a clinical trial of the stack. A test performed before transport or mixing also cannot establish later stability or freedom from contamination. Read storage claims and research peptides and why laboratory findings need human studies.1